Posted in
on April 18, 2013
by Daniel Schofield
From information gleaned during my discussions with both pharmacy and PBM partners, the most critical aspect of the pharmacist’s job is providing care to the patient/customer. Many see this priority at odds with recent regulations asking pharmacists to police compliance aspects of the prescription... CONTINUE »
Posted in
on March 8, 2013
by Daniel Schofield
With the Affordable Care Act (ACA) efforts at decreasing avenues for fraud, waste and abuse (FWA), Pharmacy is recognizing that continued challenges exist in effectively capturing the latest licensure and prescriber privilege in the claims process. In order for a provider to prescribe certain... CONTINUE »
Posted in CMS, NPI, Pharmacy
on October 10, 2012
by Daniel Schofield
You may have seen Health Market Science’s press release regarding the CMS ruling to delay mandatory Type I (individual) NPI numbers until May 6, 2013. NPI numbers are still required starting January 1st, but they can be Type II (organization) NPI numbers.
This gives a much needed respite to... CONTINUE »
Posted in DEA, Pharmacy, Scope of Practice
on July 2, 2012
by Daniel Schofield
A couple of my initial blog posts (1, 2) focused on CMS regulation of Part D covered controlled substance prescriptions and requirements to have appropriate DEA registration. Well, the DEA is jumping into the fray via some lucrative settlements resulting from investigations regarding... CONTINUE »
Posted in CMS, Compliance, Masterfile
on June 20, 2012
by Daniel Schofield
What do you expect when you partner with a vendor to deliver a service? If positive results are wishful thinking, you should consider the consequences. As a vendor, Health Market Science will always extol potential virtues of our products and services, but ultimately we will be... CONTINUE »
